Additionally, Wroblewski et al. [19] reported a significant decrease in the melanoma cell viability after exposure to obatoclax, a small molecule inhibitor which disables Bcl-2-, Bcl-xl-, Bcl-w-, and also Mcl-1. The gene discussed is BCL2; the disease is melanoma.